Healthcare provider profile · identity verified

Taro Satake, D.O.

Family Practice · ANCHORAGE, AK · NPI 1033598875

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	768	179
Losartan Potassium	Losartan Potassium	369	100
Lisinopril	Lisinopril	285	69
Amlodipine Besylate	Amlodipine Besylate	284	75
Metformin Hcl	Metformin Hcl	278	65
Levothyroxine Sodium	Levothyroxine Sodium	268	61
Tamsulosin Hcl	Tamsulosin Hcl	223	70
Gabapentin	Gabapentin	203	41
Rosuvastatin Calcium	Rosuvastatin Calcium	189	55
Donepezil Hcl	Donepezil Hcl	182	27
Pantoprazole Sodium	Pantoprazole Sodium	179	37
Omeprazole	Omeprazole	173	43
Escitalopram Oxalate	Escitalopram Oxalate	165	36
Eliquis	Apixaban	151	31
Allopurinol	Allopurinol	145	35
Montelukast Sodium	Montelukast Sodium	142	39
Metoprolol Succinate	Metoprolol Succinate	139	41
Trazodone Hcl	Trazodone Hcl	130	36
Metformin Hcl Er	Metformin Hcl	120	35
Jardiance	Empagliflozin	118	29
Sertraline Hcl	Sertraline Hcl	118	21
Hydrochlorothiazide	Hydrochlorothiazide	104	23
Fluoxetine Hcl	Fluoxetine Hcl	95	suppressed
Furosemide	Furosemide	95	19
Trulicity	Dulaglutide	93	15
Spironolactone	Spironolactone	91	17
Pravastatin Sodium	Pravastatin Sodium	88	23
Quetiapine Fumarate	Quetiapine Fumarate	88	suppressed
Duloxetine Hcl	Duloxetine Hcl	76	16
Bupropion Xl	Bupropion Hcl	73	17
Simvastatin	Simvastatin	67	18
Lamotrigine	Lamotrigine	66	suppressed
Valsartan	Valsartan	65	21
Carvedilol	Carvedilol	64	14
Ozempic	Semaglutide	64	14
Albuterol Sulfate Hfa	Albuterol Sulfate	61	24
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	55	18
Clopidogrel	Clopidogrel Bisulfate	54	12
Fluticasone Propionate	Fluticasone Propionate	52	23
Esomeprazole Magnesium	Esomeprazole Magnesium	51	11
Potassium Chloride	Potassium Chloride	51	14
Lactated Ringers	Ringer's Solution,lactated	48	suppressed
Buspirone Hcl	Buspirone Hcl	47	20
Celecoxib	Celecoxib	47	16
Mirtazapine	Mirtazapine	47	11
Mounjaro	Tirzepatide	46	12
Famotidine	Famotidine	43	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	43	suppressed
Ventolin Hfa	Albuterol Sulfate	42	13
Levetiracetam	Levetiracetam	41	suppressed
Paroxetine Hcl	Paroxetine Hcl	39	suppressed
Januvia	Sitagliptin Phosphate	38	suppressed
Myrbetriq	Mirabegron	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Mupirocin	Mupirocin	37	26
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Pregabalin	Pregabalin	36	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	14
Doxepin Hcl	Doxepin Hcl	33	14
Hydroxyzine Hcl	Hydroxyzine Hcl	33	13
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	31	suppressed
Tresiba Flextouch U-100	Insulin Degludec	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	11
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	13
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Topiramate	Topiramate	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Aripiprazole	Aripiprazole	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Rybelsus	Semaglutide	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Baclofen	Baclofen	23	12
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	11
Triamcinolone Acetonide	Triamcinolone Acetonide	23	17
Lidocaine	Lidocaine	22	suppressed
Colchicine	Colchicine	21	12
Divalproex Sodium Er	Divalproex Sodium	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	15
Glipizide	Glipizide	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Olanzapine Odt	Olanzapine	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Torsemide	Torsemide	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Hydrocortisone	Hydrocortisone	14	13
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Clotrimazole	Clotrimazole	13	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Budesonide Ec	Budesonide	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Atenolol	Atenolol	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error